| 18.06 22:10 | MÄRKTE USA/Durchatmen nach Rally - Nvidia wertvollstes US-Unternehmen |
| 18.06 18:20 | MÄRKTE USA/Verschnaufpause nach Rekordjagd |
| 18.06 15:43 | MÄRKTE USA/Wall Street kaum bewegt - Anleihen von Einzelhandel gestützt |
| 18.06 15:10 | MÄRKTE USA/Anleihen von Einzelhandel gestützt - Wall Street kaum bewegt |
| 18.06 15:04 | MÄRKTE USA/Anleihen von Einzelhandel gestützt - Wall Street kaum bewegt |
| 18.06 13:17 | dpa-AFX: Boston Scientific To Acquire Silk Road Medical For $27.50/share In Deal Valued At About $1.16 Bln |
| 18.06 13:02 | dpa-AFX: *BOSTON SCIENTIFIC AGREES TO BUY SILK ROAD MEDICAL FOR $27.50/SHR, REFLECTING ENTERPRISE VALUE OF ABOUT $1.16 BLN |
| 30.05 12:44 | dpa-AFX: *GOLDMAN STARTS BOSTON SCIENTIFIC WITH 'BUY' - PRICE TARGET 90 USD |
| 30.05 12:44 | dpa-AFX: *GOLDMAN STARTET BOSTON SCIENTIFIC MIT 'BUY' - ZIEL 90 USD |
| 18.05 18:47 | dpa-AFX: Boston Scientific : MODULAR ATP Study Of MCRM System Meets Primary Endpoints |
| 08.05 22:01 | dpa-AFX: *BOSTON SCIENTIFIC ELECTS CHERYL PEGUS TO BOARD OF DIRECTORS |
| 24.04 12:54 | dpa-AFX: ROUNDUP: Boston Scientific Boosts FY24 Outlook |
| 24.04 12:36 | dpa-AFX: *BOSTON SCIENTIFIC PROJECTS FY EPS TO BE $1.43 TO $1.48, ADJ. EPS OF $2.29 TO $2.34 |
| 24.04 12:36 | dpa-AFX: *BOSTON SCIENTIFIC EXPECTS Q2 EPS TO BE $0.35 TO $0.37 AND ADJ EPS $0.57 TO $0.59 |
| 24.04 12:35 | dpa-AFX: *BOSTON SCIENTIFIC Q1 ATTRIBUTABLE NET INCOME $495 MLN OR $0.33/SHR VS $300 MLN OR $0.21/SHR PRIOR YEAR |
| 24.04 12:34 | dpa-AFX: *BOSTON SCIENTIFIC Q1 NET SALES $3.856 BLN, UP 13.8% ON REPORTED BASIS, 15.0% ON OPERATIONAL1 BASIS |
| 24.04 12:33 | dpa-AFX: Boston Scientific Corp Q1 Profit Increases, beats estimates |
| 24.04 12:32 | dpa-AFX: *BOSTON SCIENTIFIC Q1 ADJ. EPS RISES TO $0.56 FROM $0.47 A YEAR AGO |
| 24.04 12:01 | dpa-AFX: Boston Scientific Q1 24 Earnings Conference Call 8:00 AM ET |
| 08.04 06:08 | dpa-AFX: *BOSTON SCIENTIFIC BEGINS NAVIGATE-PF STUDY OF FARAWAVE NAV PULSED FIELD ABLATION CATHETER AND FARAVIEWT SOFTWARE MODULE |
|
|
